nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipivefrin—Arrhythmia—Liothyronine—hypothyroidism	0.0599	0.181	CcSEcCtD
Dipivefrin—Hypertension—Liothyronine—hypothyroidism	0.0504	0.152	CcSEcCtD
Dipivefrin—Tachycardia—Liothyronine—hypothyroidism	0.0465	0.141	CcSEcCtD
Dipivefrin—ACHE—heart—hypothyroidism	0.0311	0.0626	CbGeAlD
Dipivefrin—Arrhythmia—Levothyroxine—hypothyroidism	0.0294	0.089	CcSEcCtD
Dipivefrin—Arrhythmia—Dextrothyroxine—hypothyroidism	0.0294	0.089	CcSEcCtD
Dipivefrin—ACHE—adrenal gland—hypothyroidism	0.0232	0.0467	CbGeAlD
Dipivefrin—Tachycardia—Levothyroxine—hypothyroidism	0.0228	0.0691	CcSEcCtD
Dipivefrin—Tachycardia—Dextrothyroxine—hypothyroidism	0.0228	0.0691	CcSEcCtD
Dipivefrin—ACHE—thyroid gland—hypothyroidism	0.0224	0.0451	CbGeAlD
Dipivefrin—Arrhythmia—Liotrix—hypothyroidism	0.0216	0.0654	CcSEcCtD
Dipivefrin—ACHE—testis—hypothyroidism	0.0192	0.0387	CbGeAlD
Dipivefrin—Hypertension—Liotrix—hypothyroidism	0.0182	0.0551	CcSEcCtD
Dipivefrin—ACHE—cerebellum—hypothyroidism	0.0177	0.0357	CbGeAlD
Dipivefrin—ADRA1A—heart—hypothyroidism	0.0172	0.0346	CbGeAlD
Dipivefrin—ADRA2C—adrenal cortex—hypothyroidism	0.017	0.0341	CbGeAlD
Dipivefrin—Tachycardia—Liotrix—hypothyroidism	0.0168	0.0508	CcSEcCtD
Dipivefrin—ADRA2C—heart—hypothyroidism	0.0164	0.033	CbGeAlD
Dipivefrin—ADRA1A—cardiovascular system—hypothyroidism	0.0162	0.0327	CbGeAlD
Dipivefrin—BCHE—heart—hypothyroidism	0.0153	0.0308	CbGeAlD
Dipivefrin—ACHE—Monoamine Transport—SLC5A7—hypothyroidism	0.0145	0.0843	CbGpPWpGaD
Dipivefrin—BCHE—cardiovascular system—hypothyroidism	0.0144	0.029	CbGeAlD
Dipivefrin—ADRA2C—pituitary gland—hypothyroidism	0.0137	0.0276	CbGeAlD
Dipivefrin—ADRA2A—heart—hypothyroidism	0.0131	0.0263	CbGeAlD
Dipivefrin—ADRA1A—adrenal gland—hypothyroidism	0.0128	0.0258	CbGeAlD
Dipivefrin—ADRA1A—blood—hypothyroidism	0.0128	0.0258	CbGeAlD
Dipivefrin—BCHE—pituitary gland—hypothyroidism	0.0128	0.0257	CbGeAlD
Dipivefrin—Hypersensitivity—Liotrix—hypothyroidism	0.0127	0.0383	CcSEcCtD
Dipivefrin—ADRA2C—adrenal gland—hypothyroidism	0.0122	0.0246	CbGeAlD
Dipivefrin—ADRA2C—blood—hypothyroidism	0.0122	0.0246	CbGeAlD
Dipivefrin—BCHE—adrenal gland—hypothyroidism	0.0114	0.023	CbGeAlD
Dipivefrin—BCHE—blood—hypothyroidism	0.0114	0.023	CbGeAlD
Dipivefrin—ADRA2C—female gonad—hypothyroidism	0.0114	0.023	CbGeAlD
Dipivefrin—ADRA2A—gonad—hypothyroidism	0.0112	0.0225	CbGeAlD
Dipivefrin—BCHE—thyroid gland—hypothyroidism	0.011	0.0222	CbGeAlD
Dipivefrin—ADRA2A—pituitary gland—hypothyroidism	0.0109	0.022	CbGeAlD
Dipivefrin—ADRA2C—testis—hypothyroidism	0.0101	0.0204	CbGeAlD
Dipivefrin—ADRA1A—liver—hypothyroidism	0.01	0.0202	CbGeAlD
Dipivefrin—ADRA1A—cerebellum—hypothyroidism	0.00981	0.0197	CbGeAlD
Dipivefrin—ADRA2A—adrenal gland—hypothyroidism	0.00977	0.0197	CbGeAlD
Dipivefrin—ADRA2A—blood—hypothyroidism	0.00976	0.0196	CbGeAlD
Dipivefrin—ADRA2C—liver—hypothyroidism	0.00957	0.0193	CbGeAlD
Dipivefrin—BCHE—testis—hypothyroidism	0.00944	0.019	CbGeAlD
Dipivefrin—ADRA2A—thyroid gland—hypothyroidism	0.00942	0.019	CbGeAlD
Dipivefrin—ADRA2C—cerebellum—hypothyroidism	0.00935	0.0188	CbGeAlD
Dipivefrin—ADRA2A—female gonad—hypothyroidism	0.00911	0.0183	CbGeAlD
Dipivefrin—BCHE—liver—hypothyroidism	0.00893	0.018	CbGeAlD
Dipivefrin—BCHE—cerebellum—hypothyroidism	0.00872	0.0175	CbGeAlD
Dipivefrin—ADRA2A—testis—hypothyroidism	0.00808	0.0163	CbGeAlD
Dipivefrin—ADRA2A—cerebellum—hypothyroidism	0.00746	0.015	CbGeAlD
Dipivefrin—ADRB2—Arf6 trafficking events—CLTC—hypothyroidism	0.00607	0.0352	CbGpPWpGaD
Dipivefrin—ADRB2—Arf6 signaling events—TSHR—hypothyroidism	0.00592	0.0343	CbGpPWpGaD
Dipivefrin—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00485	0.0281	CbGpPWpGaD
Dipivefrin—ADRB2—Arf6 trafficking events—TSHR—hypothyroidism	0.00467	0.0271	CbGpPWpGaD
Dipivefrin—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00433	0.0251	CbGpPWpGaD
Dipivefrin—ACHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00355	0.0206	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00335	0.0195	CbGpPWpGaD
Dipivefrin—BCHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00317	0.0184	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00299	0.0174	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—SLC5A7—hypothyroidism	0.00257	0.0149	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—SLC5A7—hypothyroidism	0.00229	0.0133	CbGpPWpGaD
Dipivefrin—ACHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00216	0.0125	CbGpPWpGaD
Dipivefrin—ADRB2—G alpha (s) signalling events—TSHB—hypothyroidism	0.00215	0.0125	CbGpPWpGaD
Dipivefrin—ADRB2—G alpha (s) signalling events—TSHR—hypothyroidism	0.00215	0.0125	CbGpPWpGaD
Dipivefrin—ACHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00215	0.0125	CbGpPWpGaD
Dipivefrin—BCHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00193	0.0112	CbGpPWpGaD
Dipivefrin—BCHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.00192	0.0111	CbGpPWpGaD
Dipivefrin—ACHE—Neuronal System—NEFL—hypothyroidism	0.00166	0.00961	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (12/13) signalling events—VAV3—hypothyroidism	0.00163	0.00944	CbGpPWpGaD
Dipivefrin—BCHE—Neuronal System—NEFL—hypothyroidism	0.00148	0.00857	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—TRH—hypothyroidism	0.00144	0.00833	CbGpPWpGaD
Dipivefrin—ACHE—Peptide hormone metabolism—POMC—hypothyroidism	0.00139	0.00807	CbGpPWpGaD
Dipivefrin—ACHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.00134	0.00776	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00128	0.00745	CbGpPWpGaD
Dipivefrin—ADRB2—G alpha (s) signalling events—AVP—hypothyroidism	0.00127	0.00735	CbGpPWpGaD
Dipivefrin—BCHE—Peptide hormone metabolism—POMC—hypothyroidism	0.00124	0.0072	CbGpPWpGaD
Dipivefrin—BCHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.00119	0.00692	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00117	0.00676	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00115	0.00667	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00109	0.00631	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00104	0.00602	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00104	0.00602	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00103	0.00595	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00103	0.00595	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00097	0.00563	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00097	0.00563	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000952	0.00552	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—IYD—hypothyroidism	0.000934	0.00542	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—TRH—hypothyroidism	0.000887	0.00515	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000884	0.00513	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—TRH—hypothyroidism	0.000876	0.00508	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000848	0.00492	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000848	0.00492	CbGpPWpGaD
Dipivefrin—ADRB2—G alpha (s) signalling events—POMC—hypothyroidism	0.000842	0.00489	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000839	0.00487	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—IYD—hypothyroidism	0.000833	0.00483	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—TRH—hypothyroidism	0.000829	0.00481	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—ATP5O—hypothyroidism	0.000794	0.00461	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—TSHB—hypothyroidism	0.000791	0.00459	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—TSHR—hypothyroidism	0.000791	0.00459	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000788	0.00457	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000788	0.00457	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000784	0.00455	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—TSHB—hypothyroidism	0.000781	0.00453	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—TSHR—hypothyroidism	0.000781	0.00453	CbGpPWpGaD
Dipivefrin—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	0.000755	0.00438	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—TPO—hypothyroidism	0.000747	0.00433	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—TSHB—hypothyroidism	0.000739	0.00429	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—TSHR—hypothyroidism	0.000739	0.00429	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	0.000725	0.0042	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—IYD—hypothyroidism	0.000724	0.0042	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—ATP5O—hypothyroidism	0.000708	0.00411	CbGpPWpGaD
Dipivefrin—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.0007	0.00406	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000692	0.00401	CbGpPWpGaD
Dipivefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000675	0.00392	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—TRH—hypothyroidism	0.000673	0.00391	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—TSHB—hypothyroidism	0.000671	0.00389	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—TPO—hypothyroidism	0.000666	0.00386	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	0.000646	0.00375	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	0.000646	0.00375	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000637	0.00369	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—SH2B3—hypothyroidism	0.00063	0.00366	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000617	0.00358	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—ATP5O—hypothyroidism	0.000615	0.00357	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000612	0.00355	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000604	0.00351	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—TSHB—hypothyroidism	0.0006	0.00348	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—TSHR—hypothyroidism	0.0006	0.00348	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—TSHB—hypothyroidism	0.000598	0.00347	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—SH2B3—hypothyroidism	0.000589	0.00342	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—IYD—hypothyroidism	0.000588	0.00341	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TPO—hypothyroidism	0.000579	0.00336	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000572	0.00332	CbGpPWpGaD
Dipivefrin—ADRA2B—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000517	0.003	CbGpPWpGaD
Dipivefrin—ADRA2B—G alpha (i) signalling events—POMC—hypothyroidism	0.000512	0.00297	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TRH—hypothyroidism	0.000501	0.00291	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.0005	0.0029	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—ATP5O—hypothyroidism	0.0005	0.0029	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TRH—hypothyroidism	0.000495	0.00287	CbGpPWpGaD
Dipivefrin—ADRA2C—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000483	0.0028	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—SH2B3—hypothyroidism	0.000478	0.00277	CbGpPWpGaD
Dipivefrin—ADRA2C—G alpha (i) signalling events—POMC—hypothyroidism	0.000478	0.00277	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TPO—hypothyroidism	0.00047	0.00273	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TRH—hypothyroidism	0.000468	0.00272	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—AVP—hypothyroidism	0.000466	0.0027	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000464	0.00269	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—AVP—hypothyroidism	0.00046	0.00267	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TRH—hypothyroidism	0.000455	0.00264	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TRH—hypothyroidism	0.00045	0.00261	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TSHB—hypothyroidism	0.000447	0.00259	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—TSHR—hypothyroidism	0.000447	0.00259	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TSHB—hypothyroidism	0.000441	0.00256	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—TSHR—hypothyroidism	0.000441	0.00256	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—AVP—hypothyroidism	0.000435	0.00253	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—VAV3—hypothyroidism	0.000433	0.00251	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TRH—hypothyroidism	0.000425	0.00247	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000417	0.00242	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000417	0.00242	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	0.000409	0.00238	CbGpPWpGaD
Dipivefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000407	0.00236	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TSHB—hypothyroidism	0.000406	0.00235	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—TSHR—hypothyroidism	0.000406	0.00235	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—VAV3—hypothyroidism	0.000404	0.00234	CbGpPWpGaD
Dipivefrin—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000402	0.00233	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TSHB—hypothyroidism	0.000401	0.00232	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—TSHR—hypothyroidism	0.000401	0.00232	CbGpPWpGaD
Dipivefrin—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000392	0.00227	CbGpPWpGaD
Dipivefrin—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	0.000388	0.00225	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	0.000381	0.00221	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	0.00038	0.00221	CbGpPWpGaD
Dipivefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.00038	0.0022	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TSHB—hypothyroidism	0.000379	0.0022	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—TSHR—hypothyroidism	0.000379	0.0022	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	0.000372	0.00216	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000365	0.00212	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000365	0.00212	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	0.000354	0.00205	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—TSHB—hypothyroidism	0.000346	0.002	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	0.000345	0.002	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	0.000339	0.00197	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	0.000339	0.00197	CbGpPWpGaD
Dipivefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000332	0.00193	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	0.000331	0.00192	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	0.000331	0.00192	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—VAV3—hypothyroidism	0.000328	0.0019	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	0.000311	0.00181	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	0.00031	0.0018	CbGpPWpGaD
Dipivefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000309	0.00179	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—TSHB—hypothyroidism	0.000308	0.00179	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—PIK3C2A—hypothyroidism	0.000308	0.00179	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	0.000308	0.00179	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	0.000308	0.00179	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—CLTC—hypothyroidism	0.000307	0.00178	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR ligand binding—POMC—hypothyroidism	0.000306	0.00177	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000304	0.00176	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	0.000291	0.00169	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	0.000289	0.00168	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—PIK3C2A—hypothyroidism	0.000275	0.00159	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	0.000273	0.00159	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000271	0.00157	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—VAV3—hypothyroidism	0.00027	0.00157	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TRH—hypothyroidism	0.000269	0.00156	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—TSHB—hypothyroidism	0.000268	0.00155	CbGpPWpGaD
Dipivefrin—ADRA2B—Hemostasis—IGF1—hypothyroidism	0.000266	0.00155	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TRH—hypothyroidism	0.000266	0.00154	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	0.000263	0.00153	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—POMC—hypothyroidism	0.000263	0.00152	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—AVP—hypothyroidism	0.00026	0.00151	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—SLC5A5—hypothyroidism	0.000259	0.0015	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	0.000255	0.00148	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	0.000254	0.00147	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	0.000253	0.00147	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism of proteins—IGF1—hypothyroidism	0.000253	0.00147	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TRH—hypothyroidism	0.000251	0.00146	CbGpPWpGaD
Dipivefrin—ADRA2C—Hemostasis—IGF1—hypothyroidism	0.000249	0.00144	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	0.000248	0.00144	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	0.000246	0.00143	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—VAV3—hypothyroidism	0.000245	0.00142	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	0.00024	0.00139	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	0.00024	0.00139	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	0.000239	0.00139	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	0.000239	0.00138	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TSHB—hypothyroidism	0.000237	0.00137	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—TSHR—hypothyroidism	0.000237	0.00137	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—AVP—hypothyroidism	0.000236	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	0.000236	0.00137	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	0.000235	0.00136	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—POMC—hypothyroidism	0.000234	0.00136	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	0.000232	0.00135	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—SLC5A5—hypothyroidism	0.000231	0.00134	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism of proteins—IGF1—hypothyroidism	0.000225	0.00131	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	0.000224	0.0013	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	0.000224	0.0013	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	0.000223	0.0013	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000223	0.0013	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TRH—hypothyroidism	0.00022	0.00127	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—TSHB—hypothyroidism	0.000218	0.00126	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	0.000215	0.00125	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	0.000214	0.00124	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—SH2B3—hypothyroidism	0.000211	0.00122	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	0.000207	0.0012	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TRH—hypothyroidism	0.000204	0.00118	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	0.000203	0.00118	CbGpPWpGaD
Dipivefrin—ADRA2A—Hemostasis—IGF1—hypothyroidism	0.000202	0.00117	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—SLC5A5—hypothyroidism	0.000201	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	0.0002	0.00116	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	0.0002	0.00116	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	0.000196	0.00114	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	0.000196	0.00114	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	0.000195	0.00113	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	0.000194	0.00112	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	0.000188	0.00109	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	0.000182	0.00106	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	0.000182	0.00106	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	0.000181	0.00105	CbGpPWpGaD
Dipivefrin—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	0.000175	0.00102	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	0.000175	0.00101	CbGpPWpGaD
Dipivefrin—ADRB2—GPCR downstream signaling—POMC—hypothyroidism	0.000173	0.001	CbGpPWpGaD
Dipivefrin—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	0.000164	0.000948	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—SLC5A5—hypothyroidism	0.000163	0.000945	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	0.000162	0.00094	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	0.000159	0.000922	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—PRL—hypothyroidism	0.000159	0.00092	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling by GPCR—POMC—hypothyroidism	0.000157	0.00091	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—PRL—hypothyroidism	0.000157	0.000908	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	0.000148	0.000861	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—PRL—hypothyroidism	0.000148	0.000859	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	0.000147	0.000851	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—VAV3—hypothyroidism	0.000145	0.00084	CbGpPWpGaD
Dipivefrin—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	0.000143	0.000829	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—AVP—hypothyroidism	0.000141	0.00082	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—AVP—hypothyroidism	0.00014	0.000809	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	0.000137	0.000795	CbGpPWpGaD
Dipivefrin—ACHE—Metabolism—POMC—hypothyroidism	0.000135	0.000785	CbGpPWpGaD
Dipivefrin—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	0.000133	0.00077	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—AVP—hypothyroidism	0.000132	0.000766	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	0.00013	0.000753	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—PRL—hypothyroidism	0.000129	0.000751	CbGpPWpGaD
Dipivefrin—BCHE—Metabolism—POMC—hypothyroidism	0.000121	0.0007	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	0.000121	0.0007	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—PRL—hypothyroidism	0.00012	0.000698	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	0.00012	0.000695	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—AVP—hypothyroidism	0.000115	0.000669	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	0.000111	0.000645	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—AVP—hypothyroidism	0.000107	0.000622	CbGpPWpGaD
Dipivefrin—ADRA2C—Metabolism—POMC—hypothyroidism	0.000105	0.000608	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—POMC—hypothyroidism	9.39e-05	0.000545	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—POMC—hypothyroidism	9.27e-05	0.000538	CbGpPWpGaD
Dipivefrin—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	9.03e-05	0.000524	CbGpPWpGaD
Dipivefrin—ADRB2—Signaling Pathways—IGF1—hypothyroidism	8.92e-05	0.000517	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—POMC—hypothyroidism	8.77e-05	0.000509	CbGpPWpGaD
Dipivefrin—ADRA2A—Metabolism—POMC—hypothyroidism	8.52e-05	0.000494	CbGpPWpGaD
Dipivefrin—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	8.44e-05	0.000489	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—POMC—hypothyroidism	7.67e-05	0.000445	CbGpPWpGaD
Dipivefrin—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	7.38e-05	0.000428	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—POMC—hypothyroidism	7.12e-05	0.000413	CbGpPWpGaD
Dipivefrin—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	6.85e-05	0.000398	CbGpPWpGaD
